Novartis Showcases Next-Generation Cardiovascular Therapies
BASEL, Switzerland, August 19, 2026 Novartis will present data from 10 abstracts across its cardiovascular portfolio at the 2026...
ESC Congress 2026
Advertisement
Curium Acquires Abscint to Expand Oncology PET Pipeline
Boston, Mass. & Liège, Belgium, August 10, 2026 Curium announced the completion of its acquisition of Abscint SA, a...
Tenax Therapeutics Reports Phase 3 LEVEL Results for TNX-103
Chapel Hill, N.C., August 10, 2026 Tenax Therapeutics, Inc. announced topline results from the Phase 3 LEVEL clinical trial...
AstraZeneca Reports Wainua Phase III ATTR-CM Trial Results
CAMBRIDGE, United Kingdom, July 9, 2026 AstraZeneca and Ionis Pharmaceuticals have announced results from the Phase III CARDIO-TTRansform trial...
Tenax Therapeutics to Present LEVEL Phase 3 Data at ESC
CHAPEL HILL, N.C., July 2, 2026 Tenax Therapeutics, Inc. announced that results from its Phase 3 LEVEL clinical trial...
Advertisement
